Featured on CNBC The Exchange: AbCellera CEO on raising $105 million in series B funding

“CNBC’s Meg Tirrell interviews Carl Hansen, AbCellera CEO, about how the company is working on coronavirus drugs.”

See full broadcast video on CNBC.

PARTNERSHIP

Together we can make game-changing discoveries.

Let's talk